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Tobacco consumption is consistently associated with
reduced body weight, creating an incentive to initiate
smoking and a disincentive to cease, although the health
risks associated with the habit outweigh the benefits of
reduced weight. Among smokers however, increasing con-
sumption has been associated with increased body weight.
To determine whether this contradiction reflects causal
processes, Winsløw et al.1 have applied Mendelian ran-
domization (MR) in testing the association of a genetic
variant, rs1051730 in CHRNA3, with measures of body
weight among 80 342 members of the Copenhagen
General Population Study. Among smokers, each minor
(T) allele carried was associated with an increase of about
one cigarette per day, but with a decrease in several meas-
ures of body weight, in contrast to the observational re-
sults. These results, in line with other recent studies,2–6
suggest that increased tobacco consumption causes
reduced body weight, as does smoking itself.
Here I remark on two aspects of this study that may
recur in other MR studies of this type: the restriction of
genetic effects to current smokers, and the change, in the
observational data, from decreasing to increasing body
weight as cigarette consumption increases.
The associations of rs1051730 with decreased body
weight are present in current smokers, but not in former or
never smokers, suggesting that the gene acts on body
weight only through its effect on smoking. However, by
stratifying on smoking status, the results are potentially
prone to collider bias, whereby an association is induced
between the gene and confounders of the exposure-
outcome association, creating a non-causal association be-
tween the gene and the outcome. The question is whether
smoking status should be considered as derived from the
quantity consumed (one who smokes zero cigarettes per
day is a non-smoker, others are smokers, Figure 1 arrow
a), or as an exogenous variable whose value constrains the
possible consumption (non-smokers must smoke no
cigarettes per day, smokers must smoke a positive number,
Figure 1 arrow b). Under the former, stratifying on smok-
ing status would entail a collider bias, and an association
would be seen between genotype and smoking status; but
such an association was not observed by Winsløw et al.,
nor was any association between rs1051730 and known
confounders when stratifying on smoking status. Thus the
data support the view that smoking status is distinct (i.e.
has distinct determinants) from tobacco consumption
(Figure 1 arrow b). Indeed it seems reasonable that individ-
uals would generally decide whether or not to smoke as a
precursor to developing their usual consumption.
Nevertheless, collider bias can only be completely ruled
out if the whole sample is analysed, and here the genetic as-
sociations remained significant owing to the sufficiently
high proportion of smokers among them.
The lack of genetic association among never smokers
could be interpreted as evidence against alternative path-
ways to that through smoking, in line with MR assump-
tions. However, Taylor et al.6 reported positive association
between rs1051730 and body mass index (BMI)
(P¼ 6.4 105) in a sample of 66 809 never smokers. This
trend is apparent in the 32 937 never smokers in Winsløw
et al. (P¼ 0.07, their Figure 4) and would have reached sig-
nificance (P¼ 0.01) if the same trend were observed in
66 809 subjects. Thus the exclusion restriction seems to be
violated, but as the effect is in the opposite direction to
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that observed in smokers, it need not conflict with the
qualitative conclusion that increased tobacco consumption
reduces body weight.
Observational data show a decrease in body weight at
low tobacco consumption, with increases in body weight
at higher levels of consumption (Figure 2 of Winsløw
et al.). This raises the question of whether the J-shaped pat-
tern reflects causal effects: the marginal inverse association
of rs1051730 may be driven by effects at certain consump-
tion levels. Perhaps there is a particularly strong inverse
genetic association at low consumption levels, which out-
weighs positive genetic associations at higher levels. The
conclusion that increased smoking reduces weight might
only be applicable at certain low levels of smoking.
Similar questions have recently been addressed in rela-
tion to alcohol consumption. rs1229984 in ADH1B is
associated with reduced alcohol intake and also with
reduced incidence of coronary heart disease (CHD) among
drinkers, but is not associated with CHD among non-
drinkers.7 This suggests beneficial effects of reduced in-
take, but observational data show a J-shape with increased
risk in abstainers compared with moderate drinkers.
Furthermore, for alcohol it is more plausible that absten-
tion is a special case of low intake, perhaps due to unpleas-
ant side effects associated with ADH1B variation.
rs1229984 is indeed associated with drinking status,7 so
stratification on drinking status is less defensible than it is
for smoking status.
To address these questions, methods have recently been
proposed to estimate localised causal effects that can indi-
cate whether the direction of causal effect is constant over
the range of exposure. A foundational result is that the
marginal treatment effect is a weighted sum of local aver-
age treatment effects (LATEs), defined for subgroups of
subjects with the same potential outcomes.8 Silverwood
et al.9 considered the effect of alcohol intake on markers of
cardiovascular disease. Using rs1229984 in ADH1B, they
stratified subjects according to their potential alcohol in-
take if homozygous for the common allele. With some
assumptions their approach explicitly calculates LATEs,
and was used to infer J-shaped causal associations of alco-
hol intake on several cardiovascular markers including sys-
tolic blood pressure and BMI. Burgess et al.10 proposed a
more general approach, also based on considering poten-
tial levels of exposure for a set genetic value. Because the
‘instrument-free exposure’ is by construction not associ-
ated with the genotype, stratification on it does not induce
a collider bias. With arbitrary stratification, their approach
estimates localized causal effects, distinct from formal
LATEs but also able to identify non-linear patterns in the
causal dose-response curve.
These approaches show promise for developing insight
into the pattern of causal effects when observational data
show variation in effect size or direction across the range
of exposure. One limitation is that the localized effects
apply to levels of the instrument-free exposure rather than
the exposure itself, and this distorts their interpretation.11
Thus we can only make statements about subjects with
given potential levels of exposure, rather than their actual
exposures which are arguably more relevant. Another limi-
tation is an assumption that the effect of genotype on ex-
posure is constant for all subjects. This will not hold when
there is a gene-environment interaction, as in the present
case in which the gene only affects tobacco consumption in
those who are smokers (Figure 1 arrow c); stratification on
exposure levels may be required, with attendant possibil-
ities of collider bias.
An increasing number of MR studies will consider
dosage of exposures that are present among some
subjects only. Such studies must carefully consider the rela-
tionship between presence and dosage of exposure,
together with their genetic associations. When observa-
tional effects vary over the range of exposure, it will be
informative to apply emerging methods for localized ef-
fects to infer non-linear causal effects. Such approaches
will be particularly valuable when there are conflicts be-
tween causal and observational results, which merit
exploring in greater detail.
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Figure 1. Directed acyclic graph showing causal relationships between genotype, smoking status and consumption, and body weight outcomes.
Arrow (a) applies if smoking status is defined by the quantity consumed. Arrow (b) applies if smoking status has distinct determinants and defines
the possible range of consumption. Arrow (c) is absent for non-smokers under (b). Y/N, yes or no; þve, positive; -ve, negative.
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